Ameliorating diabetes-associated atherosclerosis and diabetic nephropathy through modulation of soluble guanylate cyclase
Diabetes mellitus (DM) is an independent risk factor for micro- and macrovascular complications such as nephropathy and atherosclerosis respectively, which are the major causes of premature morbidity and mortality in Type 1 and Type 2 diabetic patients. Endothelial dysfunction is the critical first...
Main Authors: | Arpeeta Sharma, Judy Choi, Lachlan Sim, Abhiroop Dey, Muthukumar Mohan, Phillip Kantharidis, Lisa Dietz, Peter Sandner, Judy B. de Haan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-07-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2023.1220095/full |
Similar Items
-
Targeting Endothelial Dysfunction in Vascular Complications Associated with Diabetes
by: Arpeeta Sharma, et al.
Published: (2012-01-01) -
Decoding signaling mechanisms: unraveling the targets of guanylate cyclase agonists in cardiovascular and digestive diseases
by: Qinan Yin, et al.
Published: (2023-12-01) -
Tetrahydrobiopterin protects soluble guanylate cyclase against oxidative inactivation
by: Schmidt Kurt, et al.
Published: (2013-06-01) -
Changes of Adenylate Cyclase and Guanylate Cyclase in the Frontal Cortex, Lenticula, Corpus Amygdaloideum, and Hippocampus in Morphine-dependent Rats
by: Shijun Hong, et al.
Published: (2016-01-01) -
Soluble Guanylate Cyclase Stimulator Vericiguat Enhances Long-Term Memory in Rats without Altering Cerebral Blood Volume
by: Ellis Nelissen, et al.
Published: (2021-08-01)